Cited by 220Mitochondrial Function and PathologyMetabolism and Genetic DisordersCardiovascular Function and Risk Factors

A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts

Open access
Hansson, Anna, Hance, Nicole, Dufour, Eric, Rantanen, Anja, Hultenby, Kjell, Clayton, David A., Wibom, Rolf, Larsson, Nils-Göran·2004·Proceedings of the National Academy of Sciences

Abstract

We performed global gene expression analyses in mouse hearts with progressive respiratory chain deficiency and found a metabolic switch at an early disease stage. The tissue-specific mitochondrial transcription factor A ( Tfam ) knockout mice of this study displayed a progressive heart phenotype with depletion of mtDNA and an accompanying severe decline of respiratory chain enzyme activities along with a decreased mitochondrial ATP production rate. These characteristics were observed after 2 weeks of age and became gradually more severe until the terminal stage occurred at 10-12 weeks of age. Global gene expression analyses with microarrays showed that a metabolic switch occurred early in the progression of cardiac mitochondrial dysfunction. A large number of genes encoding critical enzymes in fatty acid oxidation showed decreased expression whereas several genes encoding glycolytic enzymes showed increased expression. These alterations are consistent with activation of a fetal gene expression program, a well-documented phenomenon in cardiac disease. An increase in mitochondrial mass was not observed until the disease had reached an advanced stage. In contrast to what we have earlier observed in respiratory chain-deficient skeletal muscle, the increased mitochondrial biogenesis in respiratory chain-deficient heart muscle did not increase the overall mitochondrial ATP production rate. The observed switch in metabolism is unlikely to benefit energy homeostasis in the respiratory chain-deficient hearts and therefore likely aggravates the disease. It can thus be concluded that at least some of the secondary gene expression alterations in mitochondrial cardiomyopathy do not compensate but rather directly contribute to heart failure progression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0308710100

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a mouse model with progressive cardiomyopathy induced by tissue-specific Tfam knockout causing mtDNA depletion, gene expression studies demonstrated strong induction of LON-protease expression.

    “Gene expression studies in a mouse model with progressive cardiomyopathy, induced by tissue-specific Tfam knockout causing mtDNA depletion, has demonstrated a strong induction of LON-protease expression (14).”
  • Mouse models with decreased mtDNA expression have increased cell death with little or no increase of oxidative stress.

    “We have studied a variety of mouse models with decreased mtDNA expression (10, 12–18) and such mice have increased cell death with little or no increase of oxidative stress (18, 30).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 34

  1. [1]Larsson, N.-G. & Clayton, D. A. (1995) Annu. Rev. Genet. 29 151-178. [DOI] [PubMed] [Google Scholar]
  2. [2]Larsson, N.-G. & Luft, R. (1999) FEBS Lett. 455 199-202. [DOI] [PubMed] [Google Scholar]
  3. [3]Graff, C., Bui, T. H. & Larsson, N.-G. (2002) Best Pract. Res. Clin. Obstet. Gynaecol. 16 715-728. [DOI] [PubMed] [Google Scholar]
  4. [4]Wallace, D. C. (1992) Science 256 628-632. [DOI] [PubMed] [Google Scholar]
  5. [5]Wallace, D. C. (1999) Science 283 1482-1488. [DOI] [PubMed] [Google Scholar]
  6. [6]Epstein, C. B., Waddle, J. A., Hale, W. t., Dave, V., Thornton, J., Macatee, T. L., Garner, H. R. & Butow, R. A. (2001) Mol. Biol. Cell 12 297-308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. [7]Li, H., Wang, J., Wilhelmsson, H., Hansson, A., Thoren, P., Duffy, J., Rustin, P. & Larsson, N.-G. (2000) Proc. Natl. Acad. Sci. USA 97 3467-3472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. [8]Silva, J. P., Kohler, M., Graff, C., Oldfors, A., Magnuson, M. A., Berggren, P. O. & Larsson, N.-G. (2000) Nat. Genet. 26 336-340. [DOI] [PubMed] [Google Scholar]
  9. [9]Sorensen, L., Ekstrand, M., Silva, J. P., Lindqvist, E., Xu, B., Rustin, P., Olson, L. & Larsson, N. G. (2001) J. Neurosci. 21 8082-8090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. [10]Wang, J., Wilhelmsson, H., Graff, C., Li, H., Oldfors, A., Rustin, P., Bruning, J. C., Kahn, C. R., Clayton, D. A., Barsh, G. S., Thoren, P. & Larsson, N.-G. (1999) Nat. Genet. 21 133-137. [DOI] [PubMed] [Google Scholar]
  11. [11]Wredenberg, A., Wibom, R., Wilhelmsson, H., Graff, C., Wiener, H. H., Burden, S. J., Oldfors, A., Westerblad, H. & Larsson, N.-G. (2002) Proc. Natl. Acad. Sci. USA 99 15066-15071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. [12]Larsson, N.-G., Wang, J., Wilhelmsson, H., Oldfors, A., Rustin, P., Lewandoski, M., Barsh, G. S. & Clayton, D. A. (1998) Nat. Genet. 18 231-236. [DOI] [PubMed] [Google Scholar]
  13. [13]Silva, J. P. & Larsson, N.-G. (2002) Biochim. Biophys. Acta 1555 106-110. [DOI] [PubMed] [Google Scholar]
  14. [14]Wang, J., Silva, J. P., Gustafsson, C. M., Rustin, P. & Larsson, N.-G. (2001) Proc. Natl. Acad. Sci. USA 98 4038-4043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. [15]Bruning, J. C., Michael, M. D., Winnay, J. N., Hayashi, T., Horsch, D., Accili, D., Goodyear, L. J. & Kahn, C. R. (1998) Mol. Cell 2 559-569. [DOI] [PubMed] [Google Scholar]
  16. [16]Eisen, M. B., Spellman, P. T., Brown, P. O. & Botstein, D. (1998) Proc. Natl. Acad. Sci. USA 95 14863-14868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. [17]Liu, G., Loraine, A. E., Shigeta, R., Cline, M., Cheng, J., Valmeekam, V., Sun, S., Kulp, D. & Siani-Rose, M. A. (2003) Nucleic Acids Res. 31 82-86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. [18]Förster, C., Mäkela, S., Wärri, A., Kietz, S., Becker, D., Hultenby, K., Warner, M. & Gustafsson, J. Å. (2002) Proc. Natl. Acad. Sci. USA 99 15578-15583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. [20]Wibom, R., Hagenfeldt, L. & von Dobeln, U. (2002) Anal. Biochem. 311 139-151. [DOI] [PubMed] [Google Scholar]
  20. [21]Mansour, T. E. (1965) J. Biol. Chem. 240 2165-2172. [PubMed] [Google Scholar]
  21. [22]Bass, A., Brdiczka, D., Eyer, P., Hofer, S. & Pette, D. (1969) Eur. J. Biochem. 10 198-206. [DOI] [PubMed] [Google Scholar]
  22. [23]Beutler, E., Blume, K. G., Kaplan, J. C., Lohr, G. W., Ramot, B. & Valentine, W. N. (1977) Br. J. Haematol. 35 331-340. [DOI] [PubMed] [Google Scholar]
  23. [24]Opie, L. H. & Newsholme, E. A. (1967) Biochem. J. 103 391-399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. [25]DiMauro, S., Dalakas, M. & Miranda, A. F. (1983) Ann. Neurol. 13 11-19. [DOI] [PubMed] [Google Scholar]
  25. [26]Arai, M., Matsui, H. & Periasamy, M. (1994) Circ. Res. 74 555-564. [DOI] [PubMed] [Google Scholar]
  26. [27]Razeghi, P., Young, M. E., Alcorn, J. L., Moravec, C. S., Frazier, O. H. & Taegtmeyer, H. (2001) Circulation 104 2923-2931. [DOI] [PubMed] [Google Scholar]
  27. [28]Wankerl, M. & Schwartz, K. (1995) J. Mol. Med. 73 487-496. [DOI] [PubMed] [Google Scholar]
  28. [29]Lehman, J. J. & Kelly, D. P. (2002) Clin. Exp. Pharmacol. Physiol. 29 339-345. [DOI] [PubMed] [Google Scholar]
  29. [30]Kelly, D. P., Gordon, J. I., Alpers, R. & Strauss, A. W. (1989) J. Biol. Chem. 264 18921-18925. [PubMed] [Google Scholar]
  30. [31]Sack, M. N., Rader, T. A., Park, S., Bastin, J., McCune, S. A. & Kelly, D. P. (1996) Circulation 94 2837-2842. [DOI] [PubMed] [Google Scholar]
  31. [32]Heddi, A., Stepien, G., Benke, P. J. & Wallace, D. C. (1999) J. Biol. Chem. 274 22968-22976. [DOI] [PubMed] [Google Scholar]
  32. [33]Suzuki, C. K., Suda, K., Wang, N. & Schatz, G. (1994) Science 264 273-276; and [DOI] [PubMed] [Google Scholar]; erratum (1994) 264 891. [Google Scholar]
  33. [34]Bota, D. A. & Davies, K. J. (2002) Nat. Cell. Biol. 4 674-680. [DOI] [PubMed] [Google Scholar]
  34. [35]Giraud, S., Bonod-Bidaud, C., Wesolowski-Louvel, M. & Stepien, G. (1998) J. Mol. Biol. 281 409-418. [DOI] [PubMed] [Google Scholar]

Cited by

Sorted by citations

Authors
Hansson, A., Hance, N., Dufour, E., Rantanen, A., Hultenby, K., Clayton, D. A., Wibom, R., & Larsson, N.-G.
Affiliations
  • Karolinska University Hospital (SE)
  • Departments of Medical Nutrition and Biosciences and Laboratory Medicine and Clinical Research Center, Karolinska Institutet, Novum, Karolinska University Hospital, S-141 86 Stockholm, Sweden; and Howard Hughes Medical Institute, 4000 Jones Bridge Road, Chevy Chase, MD 20815-6789
Venue
Proceedings of the National Academy of Sciences
Published
2004-02-20
Volume
101
Issue
9
Pages
3136-3141
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2051694207
Cited by
220
References
37
Citations by year
2026: 4 · 2025: 9 · 2024: 5 · 2023: 9 · 2022: 8 · 2021: 9 · 2020: 8 · 2019: 8 · 2018: 6 · 2017: 17 · 2016: 7 · 2015: 10 · 2014: 6 · 2013: 7 · 2012: 19
FWCI
5.57
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
mitochondrial cardiomyopathy, respiratory chain deficiency, metabolic switch, mitochondrial biogenesis, TFAM, mtDNA depletion, fatty acid oxidation, glycolysis, mitochondrial ATP production, heart failure progression, cardiac gene expression
MeSH terms
Animals, Crosses, Genetic, DNA-Binding Proteins, Fatty Acids, Genotype, Glycolysis, High Mobility Group Proteins, Microscopy, Electron, Mitochondria, Heart, Cardiomyopathies, Myocardium, Transcription Factors, Mice, Knockout, Mitochondrial Diseases, Animals, Genetically Modified, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review